Cleared Special

K201175 - StealthStation Cranial Software v1.3.0

K201175 is the FDA 510(k) clearance for StealthStation Cranial Software v1.3.0 by Medtronic Navigation, Inc.. It is a Class 2 Neurology device (product code HAW) cleared through the Special 510(k) pathway after a 33-day FDA review.

K201175 · Medtronic Navigation, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
33d
Days
Class 2
Risk

K201175 is an FDA 510(k) clearance for the StealthStation Cranial Software v1.3.0. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Medtronic Navigation, Inc. (Louisville, US). The FDA issued a Cleared decision on June 3, 2020 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medtronic Navigation, Inc. devices

Submission Details

510(k) Number K201175 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2020
Decision Date June 03, 2020
Days to Decision 33 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 148d · This submission: 33d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 217
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K201175.
ClearPoint Array System
K202575 · ClearPoint Neuro, Inc. · Jan 2021
StealthStation Cranial Software v1.3.2
K203639 · Medtronic Navigation, Inc. · Jan 2021
Cranial Image Guided Surgery System, Navigation Software Cranial, Navigation Software ENT, Registration Software Cranial, Automatic Registration 2.0, Ultrasound Navigation Software (BK), Intraoperative Structure Update
K192703 · Brainlab AG · Oct 2020
ROSA ONE Brain application
K200511 · Medtech S.A · May 2020
Neural Navigator
K191422 · Soterix Medical, Inc. · Apr 2020
ClearPoint System and Accessories
K200079 · Mri Interventions, Inc. · Feb 2020